Venture firm · from SEC filings
Lilly Asia Ventures
8 funds filed with the SEC, vintages 2012–2021. Combined size $4.4bn; at their peaks, these funds reported holding $5.8bn.
- Funds
- 8
- Combined size
- $4.4bn
- Aggregate peak held
- $5.8bn
- Peak − size Potential profit
- $1.4bn
- Peak ÷ size
- 1.31x
Funds
| Fund | Vintage | Size | Peak held | Peak ÷ size |
|---|---|---|---|---|
| Lilly Asia Ventures Fund I, L.P. | 2012 | not reported | $392mm 2020 | – |
| Lilly Asia Ventures Fund II, L.P. | 2012 | not reported | $811mm 2021 | – |
| Lav Biosciences Fund III, L.P. | 2015 | $200mm | $533mm 2020 | 2.66x |
| Lilly Asia Ventures Fund III, L.P. | 2015 | $100mm | $266mm 2020 | 2.66x |
| Lav Biosciences Fund IV, L.P. | 2017 | $974mm | $1.4bn 2020 | 1.47x |
| Lav Biosciences Fund V, L.P. | 2019 | $1bn | $1.4bn 2023 | 1.33x |
| Lav Fund VI Opportunities, L.P. | 2021 | $713mm | $706mm 2025 | 0.99x |
| Lav Fund VI, L.P. | 2021 | $1.4bn | $1.5bn 2025 | 1.06x |
Select a fund to see its value each year, and public pension figures where they exist. Vintage is the year of the fund’s first sale on Form D, or its first Form ADV filing.
Running one of these funds?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.